Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 Forbidden error, and its footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:20:02.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the usual study details, indicating the record is currently inaccessible due to access restrictions.
    Difference
    18%
    Check dated 2026-09-19T20:52:35.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6 instead of v3.6.5, indicating a minor update to the site version.
    Difference
    0.1%
    Check dated 2026-08-29T19:23:28.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a software update. The visible content and study information remain unchanged.
    Difference
    0.1%
    Check dated 2026-08-08T08:56:46.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, signaling an administrative update to the page version. This change does not modify any study details or content presented on the page.
    Difference
    0.1%
    Check dated 2026-07-25T06:38:51.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The study page version was updated from v3.6.2 to v3.6.3, signaling a minor revision to the record metadata.
    Difference
    0.1%
    Check dated 2026-07-03T21:44:53.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.